$1,650.00
We use our efficient, integration-free, small-molecule-based method to differentiate high-quality monocytes from human iPSCs. The differentiated monocytes recapitulate the phenotype and functional parameters of primary and in vivo monocytes.
We provide monocytes differentiated from an integration-free, control human iPSC line (ASE-9211), reprogrammed from the fibroblasts of an African American male donor. These high-purity (>90%) cells express high levels of monocyte biomarkers CD14.
These iPSC-differentiated monocytes can be used as control lines to compare the phenotype and functionality of patient-derived, genome-edited iPSC-derived monocytes for drug screening applications.
| Table Header | Table Header |
|---|---|
|
Age |
Neonate |
|
Gender |
Male |
|
Ethnicity |
African American |
|
Tissue source |
Dermal fibroblasts |
|
Reprogramming method |
Episomal |
|
Culture conditions |
Feeder-free |
Fill out the contact form below and a team member will be in touch within one business day.
